Probiotics restore enteric HDL3 secretion and improve prognosis in patients with end-stage renal disease

Xiaoxue Liu , Yuan Huang , Yixuan Li , Juan Chen , Xifan Wang , Xiaobin Wang , Liang Zhao , Yongting Luo , Peng An , Liwei Zhang , Chengying Zhang , Weijing Bian , Xingen Lei , Xiang Gao , Yinghua Liu , Yanling Hao , Huiyuan Guo , Xiaoxu Zhang , Pengjie Wang , Ran Wang , Hao Zhang , Bing Fang , Xiaolin Zhang , Longjiao Wang , Qinglu Qiu , Yuchan Zhang , Jingyi Qi , Songtao Yang , Yulong Yin , Fazheng Ren , Xiaoyu Wang

iMeta ›› 2025, Vol. 4 ›› Issue (4) : e70062

PDF
iMeta ›› 2025, Vol. 4 ›› Issue (4) :e70062 DOI: 10.1002/imt2.70062
CORRESPONDENCE
Probiotics restore enteric HDL3 secretion and improve prognosis in patients with end-stage renal disease
Author information +
History +
PDF

Cite this article

Download citation ▾
Xiaoxue Liu, Yuan Huang, Yixuan Li, Juan Chen, Xifan Wang, Xiaobin Wang, Liang Zhao, Yongting Luo, Peng An, Liwei Zhang, Chengying Zhang, Weijing Bian, Xingen Lei, Xiang Gao, Yinghua Liu, Yanling Hao, Huiyuan Guo, Xiaoxu Zhang, Pengjie Wang, Ran Wang, Hao Zhang, Bing Fang, Xiaolin Zhang, Longjiao Wang, Qinglu Qiu, Yuchan Zhang, Jingyi Qi, Songtao Yang, Yulong Yin, Fazheng Ren, Xiaoyu Wang. Probiotics restore enteric HDL3 secretion and improve prognosis in patients with end-stage renal disease. iMeta, 2025, 4(4): e70062 DOI:10.1002/imt2.70062

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Thomas, Bernadette, Kunihiro Matsushita, Kalkidan Hassen Abate, Ziyad Al-Aly, Johan Ärnlöv, Kei Asayama, Robert Atkins, et al. 2017. “Global Cardiovascular and Renal Outcomes of Reduced GFR.” Journal of the American Society of Nephrology 28(7): 2167-2179. https://doi.org/10.1681/ASN.2016050562

[2]

Modi, Zubin J., Yee Lu, Nan Ji, Alissa Kapke, David T. Selewski, Xue Dietrich, Kevin Abbott, et al. 2019. “Risk of Cardiovascular Disease and Mortality in Young Adults With End-Stage Renal Disease: An Analysis of the US Renal Data System.” JAMA Cardiology 4(4): 353-362. https://doi.org/10.1001/jamacardio.2019.0375

[3]

Fellström, Bengt C., Alan G. Jardine, Roland E. Schmieder, Hallvard Holdaas, Kym Bannister, Jaap Beutler, Dong-Wan Chae, et al. 2009. “Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis.” New England Journal of Medicine 360(14): 1395-1407. https://doi.org/10.1056/NEJMoa0810177

[4]

Karumanchi, S Ananth, and Ravi Thadhani. 2010. “Kidney Complications: Why Don't Statins Always Work?” Nature Medicine 16(1): 38-40. https://doi.org/10.1038/nm0110-38

[5]

Vaziri, Nosratola D. 2016. “HDL Abnormalities in Nephrotic Syndrome and Chronic Kidney Disease.” Nature Reviews Nephrology 12(1): 37-47. https://doi.org/10.1038/nrneph.2015.180

[6]

Pownall, Henry J., Corina Rosales, Baiba K. Gillard, and Antonio M. Gotto 2021. “High-Density Lipoproteins, Reverse Cholesterol Transport and Atherogenesis.” Nature Reviews Cardiology 18(10): 712-723. https://doi.org/10.1038/s41569-021-00538-z

[7]

Trinder, Mark, Yanan Wang, Christian M. Madsen, Tatjana Ponomarev, Lubos Bohunek, Brendan A. Daisely, HyeJin Julia Kong, et al. 2021. “Inhibition of Cholesteryl Ester Transfer Protein Preserves High-Density Lipoprotein Cholesterol and Improves Survival in Sepsis.” Circulation 143(9): 921-934. https://doi.org/10.1161/CIRCULATIONAHA.120.048568

[8]

Ghorbani, Zeinab, Asma Kazemi, Theda U. P. Bartolomaeus, Fahimeh Martami, Morvarid Noormohammadi, Arsalan Salari, Ulrike Löber, et al. 2023. “The Effect of Probiotic and Synbiotic Supplementation on Lipid Parameters Among Patients With Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis of Clinical Trials.” Cardiovascular Research 119(4): 933-956. https://doi.org/10.1093/cvr/cvac128

[9]

Rihal, Charanjit S., Stephen C. Textor, Diane E. Grill, Peter B. Berger, Henry H. Ting, Patricia J. Best, Mandeep Singh, et al. 2002. “Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention.” Circulation 105(19): 2259-2264. https://doi.org/10.1161/01.cir.0000016043.87291.33

[10]

Hein, Aaron M., Julia J. Scialla, Daniel Edmonston, Lauren B. Cooper, Adam D. DeVore, and Robert J. Mentz. 2019. “Medical Management of Heart Failure With Reduced Ejection Fraction in Patients With Advanced Renal Disease.” JACC: Heart Failure 7(5): 371-382. https://doi.org/10.1016/j.jchf.2019.02.009

[11]

Repa, Joyce. J., Stephen D. Turley, Jean-Marc A. Lobaccaro, J. Medina, L. Li, K. Lustig, Baotang Shan, et al. 2000. “Regulation of Absorption and ABC1-Mediated Efflux of Cholesterol by RXR Heterodimers.” Science 289(5484): 1524-1529. https://doi.org/10.1126/science.289.5484.1524

[12]

Nelson, Erik R., Suzanne E. Wardell, Jeff S. Jasper, Sunghee Park, Sunil Suchindran, Matthew K. Howe, Nicole J. Carver, et al. 2013. “27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology.” Science 342(6162): 1094-1098. https://doi.org/10.1126/science.1241908

[13]

Koppe, Laetitia, Elsa Nyam, Kevin Vivot, Jocelyn E. Manning Fox, Xiao-Qing Dai, Bich N. Nguyen, Dominique Trudel, et al. 2016. “Urea Impairs β Cell Glycolysis and Insulin Secretion in Chronic Kidney Disease.” The Journal of Clinical Investigation 126(9): 3598-3612. https://doi.org/10.1172/JCI86181

[14]

Majumdar, Gipsy, Jeremiah Wright, Paul Markowitz, Antonio Martinez-Hernandez, Rajendra Raghow, and Solomon S. Solomon. 2004. “Insulin Stimulates and Diabetes Inhibits O-Linked N-Acetylglucosamine Transferase and O-Glycosylation of Sp1.” Diabetes 53(12): 3184-3192. https://doi.org/10.2337/diabetes.53.12.3184

[15]

Martin, Seth S., Arif A. Khokhar, Heidi T. May, Krishnaji R. Kulkarni, Michael J. Blaha, Parag H. Joshi, Peter P. Toth, et al. 2015. “HDL Cholesterol Subclasses, Myocardial Infarction, and Mortality in Secondary Prevention: The Lipoprotein Investigators Collaborative.” European Heart Journal 36(1): 22-30. https://doi.org/10.1093/eurheartj/ehu264

[16]

Parag, H., Peter P. Toth, Seth T. Lirette, Michael E. Griswold, Joseph M. Massaro, Seth S. Martin, Michael J. Blaha, et al. 2016. “Association of High-Density Lipoprotein Subclasses and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.” European Journal of Preventive Cardiology 23(1): 41-49. https://doi.org/10.1177/2047487314543890

[17]

Malajczuk, Chris J., Neha S. Gandhi, and Ricardo L. Mancera. 2021. “Structure and Intermolecular Interactions in Spheroidal High-Density Lipoprotein Subpopulations.” Journal of Structural Biology: X 5: 100042. https://doi.org/10.1016/j.yjsbx.2020.100042

[18]

Zhang, Pan, Xifan Wang, Shenghui Li, Xuesen Cao, Jianzhou Zou, Yi Fang, Yiqin Shi, et al. 2023. “Metagenome-Wide Analysis Uncovers Gut Microbial Signatures and Implicates Taxon-Specific Functions in End-Stage Renal Disease.” Genome Biology 24(1): 226. https://doi.org/10.1186/s13059-023-03056-y

[19]

Zhang, Qin, Ying Pan, Benhua Zeng, Xiaojiao Zheng, Haifang Wang, Xueying Shen, Hui Li, et al. 2019. “Intestinal Lysozyme Liberates Nod1 Ligands From Microbes to Direct Insulin Trafficking in Pancreatic Beta Cells.” Cell Research 29(7): 516-532. https://doi.org/10.1038/s41422-019-0190-3

[20]

Wang, Xifan, Songtao Yang, Shenghui Li, Liang Zhao, Yanling Hao, Junjie Qin, Lian Zhang, et al. 2020. “Aberrant Gut Microbiota Alters Host Metabolome and Impacts Renal Failure in Humans and Rodents.” Gut 69(12): 2131-2142. https://doi.org/10.1136/gutjnl-2019-319766

RIGHTS & PERMISSIONS

2025 The Author(s). iMeta published by John Wiley & Sons Australia, Ltd on behalf of iMeta Science.

PDF

0

Accesses

0

Citation

Detail

Sections
Recommended

/